K45* (p.Lys45Ter) variant of IRS2 (Insulin receptor substrate 2)
K45* (p.Lys45Ter) in IRS2 (Insulin receptor substrate 2) is a protein-truncating change. Clinical records from UniProt describe it as variant assessed as somatic; high impact. The record also includes structural context.
K45* (p.Lys45Ter) variant details
- p.Lys45Ter
- NCI-TCGA TCGA novel
- gnomAD rs1292992712
- Variant assessed as somatic; high impact.
- Stop Gained
- UniProt: Variant assessed as somatic; high impact.
- Structural context available